Mukka Proteins Reports Mixed Financial Results Amid Rising Costs and Sales Growth in March 2025
Mukka Proteins has announced its financial results for the quarter ending March 2025, reporting net sales of Rs 381.57 crore, the highest in five quarters. Profit Before Tax reached Rs 15.95 crore, while Profit After Tax decreased to Rs 13.59 crore, amid rising interest expenses.
Mukka Proteins has recently released its financial results for the quarter ending March 2025, showcasing a mix of performance indicators. The company reported net sales of Rs 381.57 crore, reflecting a significant growth rate of 73.1% compared to the average net sales of the previous four quarters, which stood at Rs 220.39 crore. This marks the highest quarterly sales figure for Mukka Proteins in the last five quarters, indicating a positive near-term sales trend.On the profit front, the Profit Before Tax (PBT) reached Rs 15.95 crore, showing a growth of 24.0% against the average PBT of Rs 12.86 crore from the previous four quarters. This also suggests a favorable near-term trend for PBT.
However, the company faces challenges as well. Interest expenses have risen to Rs 21.23 crore, an increase of 25.99% over the previous half-year period, indicating higher borrowing costs. Additionally, the Profit After Tax (PAT) has decreased to Rs 13.59 crore, down by 9.0% compared to the average PAT of Rs 14.94 crore from the previous four quarters, reflecting a negative near-term trend.
In light of these results, Mukka Proteins has experienced adjustments in its evaluation, with its score reflecting these changes.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
